Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Aarhus University Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
The aim of the project is to:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pregnant women carrying a fetus with a sex chromosome disorder | |||
| Pregnant women carrying a fetus without a sex chromosome disorder (Controls) | |||
| Mothers of a child with a sex chromosome disorder | |||
| MOthers of a child without a sex chromosome disorder (Controls) | |||
| Children with a sex chromosome disorder | |||
| Children without a sex chromosome disorder (Controls) |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Level of DNA methylation | Levels of DNA methylation in placenta, blood, saliva, and urothelial cells | 5 years |
| Level of RNA ekspression | Level of RNA ekspression in placenta, blood, saliva, and urothelial cells | 5 years |
| Height | Height in centimeter (cm) | 5 years |
| Weight | Weight in kilogram (kg) or gram (g) | 5 years |
| Body mass index | Body mass index (BMI) in kg/m² | 5 years |
| Head circumference | head circumference in centimeter (cm) | 5 years |
| Fat mass and fat-free mass | Measure of fat mass and fat-free mass by PEA POD (kg) | 5 years |
| Development | Bayley-4 will be used to measure development. Ages & Stages Questionnaires will be used to measure development including social-emotional development drawing on the parents knowledge. | 5 years |
| Fecal microbial diversity |
| Measure | Description | Time Frame |
|---|---|---|
| Left ventricular mass | Calculation of left ventricular mass (g) | 5 years |
Not provided
Inclusion Criteria for pregnant participants in case group:
Age ≥18 years Fetus with a genetically verified sex chromosome disorder Written informed consent
Inclusion Criteria for pregnant participants in control group:
Age ≥18 years Normal first- and second-trimester ultrasound examinations Fetal growth within the normal range Written informed consent
Inclusion Criteria for mothers in the case group:
Age ≥18 years at the time of pregnancy with the child Child with a genetically verified sex chromosome disorder Written informed consent
Inclusion Criteria for mothers in the control group:
Age ≥18 years at the time of pregnancy with the child Normal first- and second-trimester ultrasound examinations during the pregnancy Normal fetal growth during the pregnancy Written informed consent
Inclusion Criteria for children in the case group:
If parents share joint custody, written informed consent must be obtained from both parents Ability to undergo a physical examination Child with a genetically verified sex chromosome disorder (prenatally or postnatally diagnosed)
Inclusion Criteria for children in the control group:
If parents share joint custody, written informed consent must be obtained from both parents Ability to undergo a physical examination
Exclusion Criteria for all groups:
Severe claustrophobia Implanted magnetic material contraindicating MRI
Not provided
Not provided
Recruitment of cases will take place at obstetric departments, departments of clinical genetics, and pediatric departments throughout Denmark.
Recruitment of controls will take place at the Department of Gynecology and Obstetrics and Department of Pediatrics, Aarhus University Hospital as well as via Facebook groups.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Anne Skakkebæk, MD, PHD | Aarhus University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Aarhus University Hospital | Aarhus | 8200 | Denmark |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D025064 | Sex Chromosome Disorders |
| D014424 | Turner Syndrome |
| D007713 | Klinefelter Syndrome |
| C535318 | Triple X syndrome |
| D014997 | XYY Karyotype |
| ID | Term |
|---|---|
| D025063 | Chromosome Disorders |
| D000013 | Congenital Abnormalities |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D030342 | Genetic Diseases, Inborn |
Not provided
Not provided
Not provided
Not provided
Not provided
blood, saliva, urine, feces, placenta
Measure of fecal microbial diversity |
| 5 years |
| Fecal microbial composition | Measurement of fecal microbial composition | 5 year |
| Left ventricular ejection fraction | Left ventricular ejection fraction measured by echocardiography (%) | 5 years |
| Left ventricular diameters | Left ventricular end-diastolic and end-systolic diameters measured by echocardiography (mm) | 5 years |
| Interventricular septal wall thickness | Interventricular septal wall thickness measured by echocardiography (mm) | 5 years |
| Heart rate | Heart rate (beats per minute) measured by electrocardiogram | 5 years |
| PR interval | PR interval (ms) measured by electrocardiogram | 5 years |
| QRS duration | QRS duration (ms) measured by electrocardiogram | 5 years |
| Corrected QT interval | Corrected QT interval (ms) measured by electrocardiogram | 5 years |
| Blood pressure | Systolic and diastolic blood pressure (mmHg) | 5 years |
| Congenital heart malformation | Congenital heart malformation assessed by echocardiography | 5 years |
| Aorta diameter | Aorta diameter (mm) measured by echocardiography | 5 years |
| Aortic valve mean gradient | Measure of aortic valve mean gradient (mmHG) | 5 years |
| Mitral valve mean gradient | Measure of mitral valve mean gradient (mmHg) | 5 years |
| Transaortic doppler flow | Measure of transaortic doppler flow (m/s) | 5 years |
| Fetal brain volume | Fetal brain volume measured by MRI (cm³) | 5 years |
| Fetal heart volume | Fetal heart volume measured by MRI (cm³) | 5 years |
| Fetal kidney volume | Fetal kidney volume measured by MRI (cm³) | 5 years |
| Fetal lever volume | Fetal lever volume measured by MRI (cm³) | 5 years |
| Fetal spleen volume | Fetal spleen volume measured by MRI (cm³) | 5 years |
| Fetal gonadal volume | Fetal gonadal volume measured by MRI (cm³) | 5 years |
| D006059 | Gonadal Dysgenesis |
| D012734 | Disorders of Sex Development |
| D014564 | Urogenital Abnormalities |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D058533 | Sex Chromosome Disorders of Sex Development |
| D052801 | Male Urogenital Diseases |
| D006330 | Heart Defects, Congenital |
| D018376 | Cardiovascular Abnormalities |
| D002318 | Cardiovascular Diseases |
| D006331 | Heart Diseases |
| D006058 | Gonadal Disorders |
| D004700 | Endocrine System Diseases |
| D007006 | Hypogonadism |
| D059786 | Abnormal Karyotype |
| D002869 | Chromosome Aberrations |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012729 | Sex Chromosome Aberrations |